8 mm in bovine muscle tissue),21-23 causes less photodam-
age, and can be focused much more precisely (down to an
effective excitation volume of 1 fL).20,24
sponding phosphoramidites would hydrolyze during the final
step (base deprotection with NH4OH, or MeNH2) of the
automated oligonucleotide synthesis (as observed by us for
similar structures; data not shown), and neither compound
has been converted into a phosphoramidite. Additionally, the
overall yields for the synthesis of Bhc-caged nucleosides
were low due to difficulties associated with the carbamate
formation.
To develop a suitable and easily accessible two-photon
caged phosphoramidite for DNA synthesis, we decided to
combine our 6-nitropiperonyloxymethyl (NPOM) caging
group strategy17,18,34,35 with the recently discovered 3-nitro-
2-ethyldibenzofuran (NDBF) group (1) (Figure 1), which
The main characteristic of a good two-photon caging group
is a high two-photon decaging cross-section δu, which is
defined as a product of a two-photon absorbance cross-
section δa and a two-photon decaging quantum yield Qu.25
Ideally δu should exceed 0.1 Goeppert-Mayer (GM) for
biological experiments in order to avoid potential tissue
damage caused by high laser powers.25-27 The two most
commonly employed two-photon caging groups are 6-bromo-
7-hydroxycoumarin-4-methyl (Bhc), with a δu of 0.72 GM
at 740 nm,25 and 8-bromo-7-hydroxyquinoline (BHQ), with
a δu of 0.59 GM at 740 nm.28 Both have been employed to
cage a variety of substrates, including carboxylic acids,
phosphates, carbonates, carbamates, diols, aldehydes, and
ketones.24,25,27-31 Bhc and BHQ caging groups decage
according to a solvent-assisted heterolysis mechanism.24,26
This makes them unsuitable for direct caging of substrates
with high pKa values,32,33 such as alcohols, phenols, amines,
and amides, hampering their application in the caging of
nucleotide bases. Recently, Furuta and co-workers have
prepared a pair of Bhc-caged nucleosides through the
installation of the Bhc group via a carbamate linkage at the
6-NH2 of deoxyadenosine and the 4-NH2 of deoxycytidine.31
However, the caging group carbamate linkage in the corre-
Figure 1. The NDBF caging group derivatives 1-4.
(11) Tang, X.; Dmochowski, I. J. Angew. Chem., Int. Ed. 2006, 45, 3523–
decages via a classical Norrish type II mechanism, enabling
efficient caging and decaging of less acidic functional
groups,33 while displaying an excellent δu of 0.6 GM (at
710 nm).
3526
.
(12) Kro¨ck, L.; Heckel, A. Angew. Chem., Int. Ed. 2005, 44, 471–473
(13) Mayer, G.; Krock, L.; Mikat, V.; Engeser, M.; Heckel, A.
ChemBioChem 2005, 6, 1966–1970
(14) Tang, X. J.; Dmochowski, I. J. Org. Lett. 2005, 7, 279–282
.
.
.
Despite its excellent photochemical properties and potential
to cage diverse substrates, no application of the NDBF group
has been reported since its discovery. We believe that this
is due to difficulties accessing it synthetically. Reported
syntheses of the alcohol 1 and the bromides 2-3 (Figure 1)
are rather low yielding and often involve laborious and
difficult purification steps.33,36 In addition to developing our
own synthetic path to 1-2, we have also synthesized the
chloromethyl ether 4 (Figure 1), which was modeled after
the NPOM caging group for caging of nitrogen heterocycles
such as nucleotide bases.17,18,34
The previously published synthesis, starting from diben-
zofuran, produced (3-nitrodibenzofuran-2-yl)-ethanol (1) in
4% total yield over 6 steps, and 1-bromo-1-(3-nitrodiben-
zofuran-2-yl)ethane (2) in 10% overall yield over 4 steps.33,36
An alternative synthetic strategy leading to the caging group
1-bromo-1-(3-nitrodibenzofuran-2-yl)-methane (3), starting
from 1-chloro-2-nitrobenzene and p-cresol, afforded the final
product 3 in only 1% total yield over 6 steps.36
(15) Ho¨bartner, C.; Silverman, S. K. Angew. Chem., Int. Ed. 2005, 44,
7305–7309
.
(16) Ting, R.; Lermer, L.; Perrin, D. M. J. Am. Chem. Soc. 2004, 126,
12720–12721
.
(17) Lusic, H.; Young, D. D.; Lively, M. O.; Deiters, A. Org. Lett. 2007,
9, 1903–1906
(18) Lusic, H.; Lively, M. O.; Deiters, A. Mol. Biosyst. 2008, 4, 508–
.
511
.
(19) Denk, W.; Strickler, J. H.; Webb, W. W. Science 1990, 248, 73–
76
.
(20) Piston, D. W. Trends Cell Biol. 1999, 9, 66–69
(21) Fisher, W. G.; Partridge, W. P.; Dees, C.; Wachter, E. A.
Photochem. Photobiol. 1997, 66, 141–155
.
.
(22) Kollias, N.; Zonios, G.; Stamatas, G. N. Vib. Spectrosc. 2002, 28,
17–23
.
(23) Detty, M. R.; Gibson, S. L.; Wagner, S. J. J. Med. Chem. 2004,
47, 3897–3915
.
(24) Zhu, Y.; Pavlos, C. M.; Toscano, J. P.; Dore, T. M. J. Am. Chem.
Soc. 2006, 128, 4267–4276
.
(25) Furuta, T.; Wang, S. S.; Dantzker, J. L.; Dore, T. M.; Bybee, W. J.;
Callaway, E. M.; Denk, W.; Tsien, R. Y. Proc. Natl. Acad. Sci. U.S.A.
1999, 96, 1193–1200.
(26) Furuta, T.; Noguchi, K. Trac-Trends Anal. Chem. 2004, 23, 511–
519
.
(27) Furuta, T.; Takeuchi, H.; Isozaki, M.; Takahashi, Y.; Kanehara,
M.; Sugimoto, M.; Watanabe, T.; Noguchi, K.; Dore, T. M.; Kurahashi,
T.; Iwamura, M.; Tsien, R. Y. ChemBioChem 2004, 5, 1119–1128
.
(28) Fedoryak, O. D.; Dore, T. M. Org. Lett. 2002, 4, 3419–3422.
We developed an optimized synthetic route to the NDBF
group 4 (Scheme 1), enabling us to synthesize sufficient
quantities of the caged phosphoramidite 11 to be used in
automated DNA synthesis. Our approach starts from com-
(29) Lu, M.; Fedoryak, O. D.; Moister, B. R.; Dore, T. M. Org. Lett.
2003, 5, 2119–2122
.
(30) Suzuki, A. Z.; Watanabe, T.; Kawamoto, M.; Nishiyama, K.;
Yamashita, H.; Ishii, M.; Iwamura, M.; Furuta, T. Org. Lett. 2003, 5, 4867–
4870
.
(31) Furuta, T.; Watanabe, T.; Tanabe, S.; Sakyo, J.; Matsuba, C. Org.
Lett. 2007, 9, 4717–4720
(32) Schmidt, R.; Geissler, D.; Hagen, V.; Bendig, J. J. Phys. Chem. A
2007, 111, 5768–5774
(33) Momotake, A.; Lindegger, N.; Niggli, E.; Barsotti, R. J.; Ellis-
.
(34) Lusic, H.; Deiters, A. Synthesis 2006, 2147–2150.
(35) Young, D. D.; Deiters, A. Bioorg. Med. Chem. Lett. 2006, 16, 2658–
.
2661
.
(36) Ellis-Davies, G. C. R.; Momotake, A. U.S. Patent Appl. 20080188645,
Davies, G. C. R. Nat. Methods 2006, 3, 35–40
.
2008.
Org. Lett., Vol. 12, No. 5, 2010
917